| NICE TA875; Semaglutide for managing obesity: A briefing for ICSs |
Prescribing bulletin |
March 2023 |
| Polypharmacy & Overprescribing: Opioid population health management |
Prescribing for Population Health |
February 2023 |
| Polypharmacy & Overprescribing: Opioid patient demographics |
Prescribing for Population Health |
February 2023 |
| Polypharmacy & Overprescribing: Opioid patient populations |
Prescribing for Population Health |
February 2023 |
| Formulary assessment – Morphine sulfate (Actimorph) orodispersible tablets |
Formulary assessment tools |
January 2023 |
| Drugs for Dementia |
Prescribing Data Report |
January 2023 |
| Formulary assessment – metolazone (Xaqua) |
Formulary assessment tools |
September 2022 |
| Optimising the use of morphine 10mg/5mL oral solution in primary care (Update) |
Medicines in Practice |
September 2022 |
| Formulary assessment – melatonin (Adaflex) for ADHD |
Formulary assessment tools |
July 2022 |
| Formulary assessment – Dacepton (apomorphine) |
Formulary assessment tools |
May 2022 |
